08 March 2010
GSK CEO Andrew Witty dedicates albendazole facility in Nashik to WHO’s Global Programme to Eliminate LF
24 February 2010
GlaxoSmithKline responds to US Senate Committee on Finance report on Avandia
20 February 2010
GSK rejects conclusions of Senate Committee on Finance Staff Report on Avandia
20 February 2010
GSK rejects conclusions reported in The New York Times story on Avandia
19 February 2010
GSK receives positive opinions in Europe for Tyverb® (lapatinib) and Votrient™ (pazopanib)
18 February 2010
GSK statement on FDA’s proposed label revisions for some asthma medicines
18 February 2010
GSK Consumer Healthcare warns consumers of potential health risks associated with long-term excessive use of zinc-containing denture adhesives
17 February 2010
GlaxoSmithKline and XenoPort receive FDA Complete Response letter for Horizant™ (GSK1838262/XP13512) for RLS
04 February 2010
GSK launches new specialist unit to research and develop medicines for rare diseases
04 February 2010
GSK announces appointment of Philippe Fauchet as President of GSK Japan
Back to top

